Previous Article | Next Article 
Journal of Virology, June 2000, p. 5525-5533, Vol. 74, No. 12
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Endotoxin Stimulates Liver Macrophages To Release
Mediators That Inhibit an Early Step in Hepadnavirus
Replication
Uta
Klöcker,1
Ursula
Schultz,2
Heinz
Schaller,1 and
Ulrike
Protzer1,*
Zentrum für Molekulare Biologie
Heidelberg (ZMBH), University of Heidelberg, D-69120
Heidelberg,1 and University Hospital,
Department of Internal Medicine II/Molecular Biology, University of
Freiburg,2 D-79106 Freiburg, Federal Republic of Germany
Received 10 December 1999/Accepted 27 March 2000
 |
ABSTRACT |
Hepadnaviruses are known to be sensitive to various extracellular
mediators. Therefore, bacterial endotoxin, which induces the secretion
of proinflammatory mediators in the liver, was studied for its effect
on hepadnavirus infection in vitro using the duck hepatitis B virus
(DHBV) model. In initial experiments, endotoxin was shown to inhibit
DHBV replication in primary duck hepatocyte cultures prepared by
standard collagenase perfusion. As a primary endotoxin target, hepatic
nonparenchymal cells (NPC) contaminating primary hepatocyte cultures,
and among these probably macrophages (Kupffer cells), were identified
to secrete polypeptide mediators into the cell culture medium.
When added during DHBV infection, these mediators elicited the
principal antiviral effect in a dose-dependent fashion. On the
molecular level, they inhibited accumulation of viral proteins as well
as amplification of the nuclear extrachromosomal DHBV DNA templates. In
hepatocytes with an established DHBV infection, DHBV protein and
progeny virus production was inhibited while the levels of established
nuclear DHBV DNA templates and viral transcripts remained unaffected.
Finally, in hepatocytes infected with a replication-deficient
recombinant DHBV-green fluorescent protein (GFP) virus, the
endotoxin-induced mediators markedly reduced GFP expression from
chimeric DHBV-GFP transcripts, indicating that the major effect is at a
level of translation of viral RNAs. Taken together, the data obtained
demonstrate that antiviral mediators, and among these the cytokines
alpha interferon (IFN-
) and IFN-
, are released from hepatic NPC,
most probably liver macrophages, upon endotoxin stimulation;
furthermore, these mediators act at a posttranscriptional step of
hepadnavirus replication.
 |
INTRODUCTION |
Hepatitis B viruses are small,
enveloped hepatotropic DNA viruses (hepadnaviruses), that replicate
their partially double-stranded DNA genome through reverse
transcription of an RNA intermediate and therefore have been classified
as pararetroviruses. Hepadnaviruses employ an episomal covalently
closed circular DNA (cccDNA) as a nuclear transcription template
and establish a cccDNA pool to regulate gene expression by copy
number. They are noncytopathic viruses, often vertically transmitted,
and establish a long-term persistent infection (for a review see
references 10 and 31). This
requires a well-balanced replication strategy that allows a variation
in viral gene expression in response to changes of the state of the
host hepatocyte as well as to extracellular stimuli.
An influence of the state of the cell is exemplified by aging cultured
hepatocytes that vastly overamplify cccDNA; this suggests that
regulatory mechanisms are evoked to compensate for reduced viral
gene expression (48). Dimethyl sulfoxide (DMSO), which influences the state of differentiation of hepatocytes, improves the
competence of cultured hepatocytes to efficiently replicate hepadnaviruses (9, 13). In duck hepatitis B virus (DHBV), the large envelope protein (L), although a structural viral protein, has been implicated in the regulation of cccDNA synthesis
(46). More recent observations suggested that it is involved
in cell-signaling, becoming phosphorylated in response to the state of
the cell (37). Extracellular soluble mediators such as the
cytokines alpha interferon (IFN-
) (34, 43, 44), IFN-
,
and tumor necrosis factor alpha (TNF-
) (15, 42), the
peptide hormone glucagon (20), glucocorticoids, and
androgens (7) have been shown to influence gene expression and replication of the hepatitis viruses.
In vivo, the liver is in permanent contact with endotoxin
(lipopolysaccharide [LPS]), a constituent of the outer cell membrane of gram-negative bacteria. In the physiological situation, endotoxin derived from the large number of gram-negative bacteria in the intestinal lumen reaches the liver via the portal vein. In the liver,
it is mainly eliminated by hepatic NPC, such as the resident macrophages, Kupffer cells, and liver sinusoidal endothelial cells (28). In particular, Kupffer cells are activated upon
contact with endotoxin to release a variety of proinflammatory
mediators such as TNF-
and prostaglandins (33).
Hepatocytes also take up endotoxin and excrete it into the bile
(30), but to date there is no evidence that hepatocytes are
stimulated by endotoxin.
Macrophages such as Kupffer cells are key players in the innate immune
response to bacterial as well as to viral infections. Activation of
macrophages is associated with an increase in cytokine production, with
an enhanced oxidative metabolism, and with an increase in phagocytotic
activity. The major role of macrophages upon contact with the
infectious agent is to recruit additional immune cells and effector
molecules to the site of infection. Endotoxin stimulation of
macrophages has been reported to suppress retroviral (1),
reoviral (32), and vaccinia virus (36) replication. Cytokines or nitric oxid, at least in part, mediates this
reduction. HIV replication can be enhanced by endotoxin-induced monokines (8), whereas endotoxin-induced chemokines suppress HIV infection in macrophages and T cells (50). In transgenic mice expressing the hepatitis B virus (HBV) envelope proteins, intraperitoneal injection of high doses of endotoxin was observed to
negatively regulate expression of the hepatitis B surface antigen in
the liver in vivo (12). It remains unknown, however, whether endotoxin influences viral replication in liver cells.
Accordingly, we wanted to investigate whether endotoxin influences
hepadnavirus replication in cultured liver cells and to study the mode
of action. We used the duck model of HBV infection (41),
which allowed us to do controlled studies in the early stages of
infection of primary duck hepatocyte cultures in vitro. Endotoxin was
found to inhibit DHBV replication in duck hepatocytes in an indirect
fashion. Inhibition occurred through the stimulation and release of
soluble mediators from hepatic NPC, most probably Kupffer cells,
present in the primary hepatocyte cultures. Our results indicate that
the endotoxin-induced inhibition of DHBV replication occurs
posttranscriptionally during the establishment of an intracellular
viral replication cycle.
 |
MATERIALS AND METHODS |
Reagents.
LPS and lipid A from Salmonella
minnesota, LPS from Escherichia coli 055:B5, and cell
culture media and supplements were purchased from Sigma Chemicals Co.
(St. Louis, Mo.). Cycloheximide and actinomycin D were purchased from
Sigma-Aldrich Chemie (Deisenhofen, Germany). L-NG-monomethylarginine and
indomethacin were purchased from Serva (Heidelberg, Germany). Duck
interferons were produced in Cos7 cells (42) or in LMH cells
(34) as described previously.
Isolation of primary duck hepatocytes.
Primary duck
hepatocytes (PDH) were isolated by standard two-step collagenase
perfusion and subsequent differential centrifugation essentially as
described previously (9). Briefly, livers from 2- to
3-week-old ducklings were perfused via the portal vein and hepatocytes
were sedimented three times at 50 × g and seeded at a
density of 106 cells per ml (2 × 105/cm2) in 6- or 12-well plates or
60-mm-diameter dishes. Cells were maintained at 37°C (5%
CO2) in supplemented Williams E medium (50 µg of
gentamicin per ml, 50 µg of streptomycin per ml, 50 IU of penicillin
per ml, 2.25 mM L-glutamine, 0.06% glucose, 23 mM HEPES
[pH 7.4], 4.8 µg of hydrocortisone per ml, 1 µg of inosine per
ml, 1.5% DMSO) without the addition of serum.
Isolation and stimulation of hepatic NPC.
NPC (especially
Kupffer cells and sinusoidal endothelial cells) are known to make up a
significant portion of liver cells after collagenase perfusion
(22). Liver cell cultures enriched for NPC were prepared by
a two-step differential centrifugation of the total cell suspension
from DHBV-negative ducklings obtained by two-step collagenase perfusion
(2). Hepatocytes were removed by centrifugation at
50 × g. Subsequently, smaller NPC present in the
supernatant were sedimented by centrifugation at 250 × g and seeded onto 6-well plates at a density of 107
cells/ml (2 × 106 cells/cm2) in the
maintenance medium described above. Sinusoidal endothelial cells were
purified from the NPC suspension by centrifugal counterflow elutriation
(24). Cells were stimulated 24 h postplating with 20 ng
of LPS per ml in maintenance medium for 3 h. After extensive washing to remove the LPS, the culture medium was collected after 12 h, centrifuged to remove cell debris, and stored at
70°C
until further use. To obtain control supernatants, NPC were treated accordingly, except that no LPS was added. Unless otherwise stated, primary hepatocyte cultures were incubated with a 1:2 dilution of the
NPC media during DHBV infection and subsequent cultivation.
Characterization of primary duck liver cell cultures.
Liver
sinusoidal endothelial cells were identified by receptor-mediated
uptake of acetylated low-density lipoprotein (LDL) (21), and
Kupffer cells were identified as macrophages by phagocytosis. PDH
cultures were incubated with either tetramethyl rhodamine isocyanate
labeled, red fluorescent acetylated LDL (Dil-Ac-LDL; Paesel & Lorei,
Duisburg, Germany [21]) or 1-µm-diameter
amine-modified yellow-green fluorescent latex beads (Sigma-Aldrich
Chemie [29]) for 2 to 3 h. After careful washing,
labeled NPC were identified by fluorescence microscopy.
Characterization of the endotoxin-induced mediators.
To
estimate the molecular weight of endotoxin-induced mediators, 2.5 ml of
endotoxin-conditioned NPC medium was subjected to size exclusion
chromatography on a Sephadex column with an exclusion limit of 5 × 103 for globular protein (PD10 columns; Amersham
Pharmacia Biotech, Uppsala, Sweden) according to the manufacturer's
instructions. One 3.5-ml fraction containing proteins with masses of
>5 kDa and a second 5-ml fraction containing proteins with masses of <5 kDa were eluted.
To characterize the class of mediators, actinomycin D (100 ng/ml), an
inhibitor of transcription; cycloheximide (20 µg/ml), an inhibitor of
translation; indomethacin (500 nM), a cyclooxygenase inhibitor blocking
prostaglandin synthesis; or
L-N-monomethylarginine (47 nM), a competitive
inhibitor of inducible nitric oxide synthase, was added to NPC cultures
either with or without endotoxin. The doses of actinomycin D and
cycloheximide were chosen to completely block synthesis of viral
proteins after addition to hepatocyte cultures; the doses of
indomethacin and
L-NG-monomethylarginine were
fivefold greater than the 50% inhibitory concentration.
To determine whether interferons are secreted by LPS-stimulated NPC, we
monitored the accumulation of Mx and IRF-1 transcripts, as markers for
the presence of IFN-
/
or IFN-
, respectively, in PDH cultures
by Northern blotting. Cells from a 60-mm-diameter dish (corresponding
to 3.5 × 106 cells) were lysed 24 h after the
addition of endotoxin-stimulated or control NPC medium, and total RNA
was prepared with the RNeasy RNA preparation kit (Qiagen, Hilden,
Germany). RNA was size fractionated by electrophoresis through a 1.2%
formaldehyde agarose gel and blotted onto a nylon membrane. The
membranes were sequentially hybridized with radiolabeled chicken IRF-1
(23), duck Mx (4), and chicken
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probes as
described previously (42).
DHBV infection of primary duck hepatocytes.
For in vitro
DHBV infection, a duck serum containing 1010 virions per ml
(measured as enveloped DNA-containing particles) was used
(20). Replication-deficient recombinant DHBV (rDHBV) in which the S gene was replaced by a green fluorescent protein (GFP) coding sequence (rDHBV-GFP) were produced as recently described (34), concentrated by precipitation with polyethylene
glycol, and stored in phosphate-buffered saline (PBS)-10% glycerol at
20°C. DHBV 16-containing duck serum was diluted in prewarmed maintenance medium to a multiplicity of infection (MOI) of 50 virus
particles (vp) per cell; rDHBV-GFP was diluted to an MOI of 100 or 150 vp/cell. Cells were infected overnight at 37°C at day 2 postplating
in the presence or absence of LPS and/or other supplements as indicated
below. The inoculum was washed off twice with Hank's buffered salt
solution, and the cells were maintained as described above in the
presence of the various supplements. Daily visual inspection of the
cell cultures and crystal violet staining of living cells after up to 8 days of treatment revealed no evidence of a cytotoxic effect. The
number of cells in treated and untreated cell cultures was determined
by nuclear staining with Hoechst dye 33258. PDH with an established
DHBV infection obtained from 2- to 3-week-old ducklings infected with
109 DHBV 16 particles the day after hatching were subjected
to treatment from 2 h postplating until the end of the culture period.
Assays detecting DHBV infection. (i) Immunofluorescence staining
of intracellular viral protein.
Cell monolayers were fixed with
100% methanol at
14°C at day 4 postinfection (p.i.). The number of
infected cells was determined by immunofluorescence staining of
intracellular viral antigens using a polyclonal rabbit antiserum
recognizing the pre-S domain of DHBV L protein (39) and one
recognizing the DHBV core protein (40) as well as a
DTAF-labeled secondary goat-anti-rabbit immunoglobulin G antibody
(Dianova, Hamburg, Germany).
(ii) Detection of GFP fluorescence.
Cells infected with
rDHBV-GFP were monitored daily for green fluorescence by fluorescence
microscopy using a standard fluorescein isothiocyanate filter set with
excitation by blue light (488 nm) and photographed at maximal fluorescence.
(iii) Western blot analysis of intracellular viral proteins.
For Western blot analysis of intracellular viral protein,
106 primary hepatocytes were lysed at day 6 p.i. in
250 µl of protein sample buffer (200 mM Tris-Cl [pH 8.8], 10%
glucose, 5 mM EDTA, 0.1% bromophenol blue, 3% sodium dodecyl sulfate
[SDS], 2%
-mercaptoethanol). Twenty-five microliters (equivalent
to 105 cells) of lysates of newly infected cells or 10 µl
(equivalent to 4 × 104 cells) of lysates of cells
from DHBV-infected ducklings was separated by SDS-10% polyacrylamide
gel electrophoresis (PAGE) and blotted to a polyvinylidene difluoride
membrane, and viral proteins were detected using the antisera against
DHBV-L or -core protein or monoclonal antibody 4F8 recognizing amino
acids 100 to 105 of the pre-S domain (kindly provided by Christa Kuhn,
Zentrum für Molekulare Biologie, University of Heidelberg,
Heidelberg, Germany) and an appropriate peroxidase-conjugated secondary
antibody (Dianova). Protein bands were visualized using the enhanced
chemiluminescence system (ECL; Amersham, Cleveland, Ohio) or quantified
on a fluoroimager (Molecular Dynamics, Sunnyvale, Calif.) using the
enhanced chemifluorescence system (ECF; Amersham).
(iv) DNA dot blot analysis of viral DNA.
A 50-µl volume
(2 × 105 cells) of protein sample buffer lysate was
digested with proteinase K (2 mg/ml in 250 µl of 10 mM Tris [pH
8.0], 100 mM NaCl, 25 mM EDTA, 0.5% SDS). Intracellular DNA was
purified by standard phenol-chloroform extraction. DHBV DNA from 6 × 104 cells or 500 µl of cell culture medium
(corresponding to 5 × 105 cells) was detected by dot
blot hybridization with a 32P-labeled DHBV DNA probe
(specific activity, ~108 cpm/µg) and quantified using a
PhosphorImager (Molecular Dynamics). A dilution series of DHBV DNA
served as a standard.
(v) Northern blot analysis of intracellular viral RNA.
Intracellular viral RNA was analyzed by Northern blot. Total RNA was
prepared as described previously (3) from 8 × 106 hepatocytes isolated from DHBV-infected ducklings at
the time points indicated or from 1.2 × 107 newly
infected hepatocytes at day 4 p.i. mRNA was purified using oligo(dT)25-coated magnetic beads (Dynabeads; Dynal, Oslo
Norway). Half of the mRNA was size fractionated by electrophoresis
through a 1.0% formaldehyde agarose gel and blotted onto nylon
membrane. Viral RNAs were detected using a 32P-labeled DHBV
DNA probe, and chimeric DHBV-GFP RNAs were detected using a
32P-labeled GFP DNA probe.
(vi) Southern blot analysis of intracellular viral DNA.
cccDNA was isolated by a modification of the Hirt lysis method
(46). Briefly, 4 × 106 PDH from a
DHBV-positive duck or in vitro-infected PDH were lysed in 1 ml of lysis
buffer (50 mM Tris-HCl [pH 8.0], 10 mM EDTA, 150 mM NaCl, 1% SDS).
Protein-bound DNA was precipitated on ice for 5 min with 250 µl of
2.5 M KCl and removed by centrifugation. cccDNA was isolated from
the supernatant by phenol-chloroform extraction, ethanol precipitated,
and dissolved in 100 µl of 10 mM Tris-0.1 mM EDTA [pH 8.0]. After
RNase digestion (5 µg/ml, 15 min, 37°C), 25 µl of the DNA was
analyzed by Southern blotting and DHBV DNA was detected by a
32P-labeled DHBV DNA probe.
 |
RESULTS |
Endotoxin inhibits DHBV replication in hepatocyte cultures.
To
test whether endotoxin influences hepadnaviral replication in cultured
primary duck hepatocytes, LPS was added in low physiological concentrations (11) to the hepatocyte medium during the DHBV infection period. In the presence of LPS, the amount of intracellular viral protein, as determined by Western blot analysis of cellular lysates, was reduced in a dose-dependent fashion. This was accompanied by a reduction in progeny DHBV release into the cell culture media, as
determined by DHBV DNA dot blot analysis (Fig.
1). In different experiments, 10 pg to 10 ng of LPS/ml reduced the amount of progeny DHBV from day 4 to day
8 p.i. by two- to sixfold. No difference between various endotoxin
preparations was observed. In contrast to LPS, the addition of lipid A,
the conserved lipid constituent of LPS, showed no effect on DHBV
replication in hepatocyte cultures (Fig. 1).

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 1.
Endotoxin, but not lipid A, inhibits DHBV replication in
vitro. When added to PDH cultures during DHBV infection, low
concentrations of LPS inhibited DHBV core protein synthesis (shown by
Western blot analysis of cellular lysates taken at day 8 p.i.) as
well as DHBV progeny release (shown by dot blot analysis of cell
culture media collected from day 4 to 8 postinfection). In contrast to
LPS, lipid A, the lipid portion of endotoxin, did not elicit an
inhibitory effect.
|
|
PDH cultures contain hepatic NPC.
The liver consists of
various cell types, including hepatocytes which represent 60 to 65% of
the liver cell population and NPC which account for 35 to 40% (2,
5). NPC include 15 to 20% sinusoidal endothelial cells, 8 to
12% Kupffer cells, and lower amounts of stellate cells, intrahepatic
lymphocytes, and bile duct epithelial cells. Primary hepatocyte
cultures from mouse or rat are known to contain 3 to 20% NPC (2,
22). Therefore, PDH cultures were analyzed for the presence of
NPC, which may secrete mediators in response to endotoxin. For any
given PDH preparation, 5 to 10% of the total number of cells were
identified, by uptake of acetylated LDL, to be liver sinusoidal
endothelial cells and 0.5 to 2% were identified, by phagocytosis of
1-µm-diameter beads, to be Kupffer cells (Fig.
2).

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 2.
Characterization of NPC in PDH cultures. Liver
macrophages (Kupffer cells) present in PDH cultures (B, phase contrast)
were identified by their ability to phagocytose 1 µM
green-fluorescent latex beads (A). Liver sinusoidal endothelial cells
in the primary hepatocyte cultures were identified by receptor-mediated
uptake of acetylated LDL labeled with a red-fluorescent dye (C).
|
|
Endotoxin stimulates hepatic NPC to secrete antiviral
mediators.
To assess whether endotoxin elicits its effect via NPC
stimulation, NPC cultures enriched by differential centrifugation for Kupffer cells by approximately 10-fold and sinusoidal endothelial cells
enriched by approximately 2-fold were treated with endotoxin and
supernatants were tested for an antiviral effect on hepatocyte cultures
during DHBV infection. Significantly fewer hepatocytes treated with
supernatant from endotoxin-treated NPC stained positive for
intracellular DHBV core and L protein than untreated hepatocytes (compare Fig. 3A and B), whereas
supernatants from unstimulated NPC showed no effect (Fig. 3C). In
comparison, addition of LPS to hepatocyte cultures had an only minor
effect (Fig. 3D). The number of cells in treated and untreated cell
cultures was equivalent, as determined by nuclear staining (Fig. 3E and
F), excluding a cytotoxic effect of the supernatant.

View larger version (128K):
[in this window]
[in a new window]
|
FIG. 3.
Soluble mediators secreted by endotoxin-stimulated liver
macrophages inhibit DHBV infection of hepatocytes. Immunofluorescence
staining of DHBV core and L protein in primary duck hepatocytes (day
4 p.i.) in untreated (A and E) and treated (B-D and F) hepatocyte
cultures. The addition of supernatant of endotoxin-stimulated hepatic
NPC significantly reduced the number of hepatocytes staining positive
for the DHBV proteins (B), whereas the supernatant of unstimulated
hepatic NPC showed no effect (C). Direct addition of endotoxin to
hepatocyte cultures had an inferior effect (D). Nuclear staining proved
that the same number of untreated cells (E) and cells treated with the
supernatant of endotoxin-stimulated hepatic NPC (F) were stained. This
identified mediators secreted by hepatic NPC after endotoxin
stimulation to be responsible for the inhibition of DHBV replication.
|
|
Inhibition of DHBV replication diminished in a dose-dependent
fashion (1:20 to 1:2,000 dilution) (Fig.
4) with little or no detectable
progeny DHBV, intracellular DHBV DNA, or DHBV protein following
incubation with maximal concentration (1:2 dilution) of supernatant
from endotoxin-treated NPC (Fig. 4). In contrast, supernatants of
endotoxin-treated purified duck liver sinusoidal endothelial cells did
not inhibit DHBV replication (data not shown). From these data, we
conclude that endotoxin inhibits productive DHBV infection indirectly:
it stimulates hepatic NPC, most probably liver macrophages (Kupffer
cells), to secrete soluble mediators.

View larger version (77K):
[in this window]
[in a new window]
|
FIG. 4.
Endotoxin-induced mediators block DHBV replication in a
dose-dependent fashion. Soluble mediators released by
endotoxin-stimulated liver macrophages abrogated in primary hepatocytes
the synthesis of intracellular DHBV core and L protein (Western blot
analysis of hepatocyte lysates on day 8 p.i.), intracellular DHBV
DNA (dot blot analysis of DNA extracted from hepatocyte lysates on day
8 p.i.) and DHBV progeny release (DNA dot blot analysis of cell
culture medium collected from day 4 to 8 p.i.). The effect
diminished in a dose-dependent fashion (+LPS); supernatants of
unstimulated NPC ( LPS) did not affect DHBV replication.
|
|
Endotoxin induces expression of antiviral cytokines in hepatic
NPC.
Endotoxin-induced mediators were analyzed for their
approximate molecular weight by size exclusion chromatography. Two
fractions containing molecules of <5 kDa or >5 kDa were tested for
their antiviral effect when added during DHBV infection. Figure
5A shows that the inhibitory effect on
DHBV replication (monitored by DHBV protein synthesis) was elicited by
molecules with molecular masses greater than 5 kDa. Heat treatment for
10 min at 95°C inactivated the antiviral activity of the supernatant,
indicating that the active component was proteinaceous (data not
shown).

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 5.
Endotoxin-induced mediators are polypeptides.
(A) Supernatant of endotoxin-stimulated hepatic NPC was subjected to
size exclusion chromatography. Fractions containing molecules with
molecular masses of <5 kDa or >5 kDa, respectively, were added to
primary hepatocytes during DHBV infection. Western blot analysis of
DHBV core protein in primary hepatocytes (day 7 p.i.) revealed
that mediators of >5 kDa were responsible for the inhibitory effect on
DHBV replication. (B) Addition of protein synthesis inhibitors
actinomycin D and cycloheximide during endotoxin stimulation (+LPS)
prevented production of inhibitory mediators by hepatic NPC (Western
blot analysis of intracellular DHBV core and L protein in hepatocyte
lysates day 7 p.i.). Supernatant of unstimulated non-parenchymal
liver cells ( LPS) used as a control did not affect DHBV protein
synthesis in duck hepatocytes.
|
|
Inhibition of protein synthesis (by actinomycin D and cycloheximide)
during endotoxin stimulation largely abolished the production of the
antiviral mediators (Fig. 5B). In contrast, neither the addition of
indomethacin, an inhibitor of prostaglandin synthesis, nor the addition
of L-NG-monomethylarginine, a
blocker of the inducible nitric oxide synthase to NPC cultures during
endotoxin stimulation, had any effect (data not shown). Taken together,
these data showed that polypeptides, most probably cytokines,
are the responsible antiviral mediators secreted by NPC upon endotoxin challenge.
Northern blot analysis of RNA extracted from lysates of treated,
untreated, and mock-treated hepatocyte cultures revealed that Mx and
IRF-1 transcripts were upregulated in hepatocyte cultures treated
either with 10 ng of endotoxin per ml or with the endotoxin-induced mediators (1:2 dilution) (Fig. 6). The
gene encoding Mx is induced by IFN-
, while IRF-1 transcription is
mainly induced by IFN-
(IRF-1) (Fig. 6, last two lanes
[42]). This result suggests that supernatants of
endotoxin-stimulated NPCs contain the cytokines IFN-
and IFN-
.

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 6.
IFN- and IFN- are released after endotoxin
treatment. Hepatocyte cultures were treated either with endotoxin
(+LPS), with plain medium ( LPS), with supernatant from endotoxin
stimulated (NPC + LPS), with supernatant from unstimulated hepatic
NPC (NPC LPS), or with supernatants from COS cells transfected
with expression constructs encoding duck IFN- or duck IFN- and
lysed 24 h after treatment. Samples (10 µg) of total RNA were
analyzed by Northern blotting. The blot was sequentially hybridized
with radiolabeled chicken IRF-1, duck Mx, and chicken GAPDH cDNA probes
as described previously (42). IRF-1 transcripts accumulate
after treatment of cells with IFN- ; Mx transcripts accumulate after
treatment of cells with IFN- . IRF-1 as well as Mx genes were induced
in hepatocyte cultures treated either with LPS or with
endotoxin-induced mediators released by nonparenchymal liver cells,
indicating that both cytokines were among the endotoxin-induced
mediators.
|
|
Endotoxin-induced mediators interfere with accumulation of progeny
DHBV cccDNA.
As shown in Fig. 4, intracellular viral proteins,
total intracellular DHBV-DNA and progeny virus production were reduced
in parallel after addition of the endotoxin-induced mediators,
suggesting that an early step during the establishment of an
intracellular DHBV replication was affected. In time-course
experiments, an identical inhibitory effect was also observed when the
endotoxin-induced mediators were added up to 24 h after
termination of DHBV infection by exposure to pH 2.2. A reduced
inhibition was observed when endotoxin-induced mediators were added
48 h p.i. (data not shown). This timespan coincides with the time
of initial amplification of nuclear cccDNA in vitro (20,
25). Southern blot analysis confirmed that the treatment blocked
the accumulation of progeny cccDNA after DHBV infection (Fig.
7).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 7.
Endotoxin-induced mediators inhibit accumulation of
cccDNA after DHBV infection. Primary duck hepatocytes were infected
with DHBV at day 2 postplating with (+) or without ( ) the addition of
medium from endotoxin-stimulated NPC. DHBV cccDNA was isolated from
duck hepatocytes at the time indicated and subjected to Southern blot
analysis. Gel migration positions of relaxed circular (rc), linear, and
covalently closed circular (ccc) forms of viral DNA are indicated. In
cells treated with endotoxin-induced mediators released by hepatic NPC,
the accumulation of progeny cccDNA was observed in the untreated
cells after DHBV infection was blocked. M, marker.
|
|
Endotoxin-induced mediators affect hepadnaviral gene
expression.
To further define the step during intracellular
DHBV replication which was blocked by the endotoxin-induced mediators,
we used PDH isolated from an DHBV-infected duckling. In contrast to in
vitro-infected PDH, an intracellular replication cycle was already
established in these cells.
As depicted in Fig. 8, hepatocytes
with an established DHBV infection showed significant variation
in virus production depending on the time postplating. Preformed virus
was released during the first 24 h postplating; then DHBV
production decreased two- to threefold by day 3; thereafter, virus
production again increased until it reached a constant level around day
8. If these cells were treated with endotoxin-induced mediators
directly after plating, progeny virus production was reduced from day 2 to 4 postplating; from day 4 postplating, progeny production was
undetectable by DHBV DNA dot blot (Fig. 8). Even if only added from day
5 postplating, endotoxin-induced mediators resulted in a continuous
reduction of progeny virus production (4-fold at day 11, about 50-fold
at day 21 postplating [data not shown]).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 8.
Endotoxin-induced mediators block progeny virus
production by hepatocytes with an established DHBV infection.
Hepatocytes with an established DHBV infection show significant changes
in virus production depending on the time postplating: preformed virus
is released directly after plating before DHBV production goes down
until day 3 postplating (quantitation of extracellular DHBV-DNA after
dot blot analysis of cell culture media). From day 4 postplating, virus
production increases again until it reaches a constant level around day
8 postplating. When endotoxin-induced mediators were added to these
cells, initial virus release was identical to that from cells treated
with supernatant from unstimulated NPC. After 2 days, progeny virus
production decreased in treated cells and stayed at a low level.
|
|
Treatment with the endotoxin-induced mediators during the whole culture
period, however, diminished neither preexisting cccDNAs serving as
transcription templates (as analyzed by Southern blotting [Fig.
9A]) nor genomic or subgenomic viral
transcripts (as analyzed by Northern blotting [Fig. 9B]). In the same
cells, the amount of relaxed circular and single-stranded replicative
intermediates was reduced by a factor of three (at day 6 postplating)
with single-stranded DNA (ssDNA) being reduced earlier (from day 1 postplating) than relaxed circular DNA (rcDNA) (after day 2 postplating). Levels of viral proteins were also reduced during
treatment (as shown by Western blotting [Fig. 9C]). Quantitation
using a fluoroimager revealed a threefold reduction of the amount of
core and L protein at day 10 postplating in cells treated with the
endotoxin-induced mediators. Metabolic 35S-labeling of the
cells also showed a two- to threefold reduction of L protein synthesis
in treated cells, whereas the amount of cellular proteins was equal in
treated and untreated cells (data not shown). Taken together, these
data suggest that the endotoxin-induced mediators interfere with a
posttranscriptional step required for intracellular DHBV replication.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 9.
Viral cccDNA and transcript levels are not
influenced by endotoxin-induced mediators in hepatocytes with an
established infection. Hepatocytes used were isolated from an
DHBV-infected duckling, and endotoxin-induced mediators were added to
these cells directly postplating. The amount of DHBV cccDNA during
treatment was determined by Southern blot analysis (A), the amount of
DHBV RNAs was determined by Northern blot analysis (B), and the amount
of DHBV core and L protein was determined by Western blot anlysis
(using ECL for detection of core and ECF for detection of L protein on
the same blot) (C). No changes in the level of cccDNA or of viral
RNAs were observed, whereas protein levels were significantly reduced
during treatment with endotoxin-induced mediators (+) in comparison
to untreated ( ) cells. Duck hepatocytes were lysed for
isolation of viral nucleic acids and for analysis of viral proteins at
the time point indicated. Gel migration positions of relaxed circular
(rc), linear, and covalently closed circular (ccc) forms of viral DNA
(A) and of pregenomic and subgenomic RNAs (B) are indicated. M,
marker.
|
|
Endotoxin-induced mediators act before encapsidation of viral
RNAs.
To distinguish whether the antiviral effect of
endotoxin-induced mediators is at the level of translation or
encapsidation of viral RNAs or whether it requires formation of viral
capsids, we used rDHBV-GFP, a recombinant, replication-deficient DHBV
carrying a GFP gene as described recently (34). In the rDHBV
genome, the S coding region is exchanged for a GFP coding region which disrupts the overlapping viral polymerase open reading frame (Fig. 10A) (3). Because polymerase
is lacking, pregenomic RNA cannot be encapsidated and reverse
transcribed and amplification of the viral genome is prevented
(3). GFP and DHBV core protein are the only gene products
expressed from the incoming viral genome (Fig. 10A).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 10.
Expression of GFP after infection with a recombinant
DHBV transferring a GFP gene is markedly reduced by endotoxin-induced
mediators. Primary duck hepatocytes were infected with rDHBV-GFP at an
MOI of 150 vp/cell. rDHBV-GFP is produced using construct pCD16-S-GFP
as recently described (34). After infection, chimeric
DHBV-GFP pregenomic (3.65-kb) and subgenomic (2.25-kb) messages are
detected in which GFP sequences are flanked by the authentic DHBV
sequences including the complete untranslated 5' leader, the authentic
AUG, and the first four codons of the S-message as well as 3' DHBV
sequences up to the DHBV polyadenylation site (A). Fluorescence
microscopy of infected cells (B) revealed that in untreated cultures,
markedly more hepatocytes expressed GFP at a detectable level than in
cultures treated with supernatant from endotoxin-stimulated NPC. By
Northern blot analysis using a GFP probe (C), however, the amount of
GFP-containing transcripts was equal in treated and untreated cells at
day 4 p.i.
|
|
Although the number of hepatocytes which expressed GFP at a detectable
level was reduced at least 20-fold (Fig. 10B), the number of chimeric
DHBV-GFP transcripts remained constant (Fig. 10C) when endotoxin-induced mediators were present during rDHBV-GFP infection. This shows that the same number of cells was infected in treated and
untreated cultures and that transcriptional activity from the
incoming DHBV-GFP genome was unchanged. It may be important that the
expression level of GFP varies markedly between infected cells on the
same dish (34). A few cells always remain unaffected by the treatment after infection with DHBV-GFP, as in infection with
DHBV. Together with the data presented above, the reduction of GFP
expression therefore strongly suggests that translation from viral
transcripts is affected. This experiment shows, in addition, that the
endotoxin-induced mediators elicit an effect prior to
encapsidation of pregenomic RNA.
 |
DISCUSSION |
The data presented here demonstrate that endotoxin inhibits
hepadnavirus replication in vitro in an indirect, noncytopathic fashion: it stimulates hepatic NPC, most probably liver macrophages, to
secrete soluble antiviral mediators. When present during DHBV infection
of duck hepatocytes, the antiviral mediators blocked intracellular
viral protein synthesis and progeny virus production as well as
cccDNA amplification, indicating that an early step of the DHBV
replication cycle was affected. In hepatocytes isolated from a
DHBV-infected duck, in which the intracellular replication cycle and a
cccDNA pool were already established, viral protein synthesis was
reduced and progeny virus production was blocked but cccDNAs and
viral transcripts remained unaffected. These data strongly suggest that
endotoxin-induced mediators act at a posttranscriptional step rather
than affecting the initial steps of DHBV infection such as virus
uptake, nuclear import of the viral genome, or conversion of the
viral genome into nuclear cccDNA.
In addition, we showed that GFP expression was inhibited after
infection with a replication-deficient recombinant virus, DHBV-GFP (34), which does not encapsidate pregenomic RNA and thus
expresses GFP from the incoming viral genome. The number of chimeric
DHBV-GFP genomic and subgenomic transcripts present,
however, was not affected. GFP is translated from the subgenomic
DHBV-GFP transcript which contains the authentic, relatively long
300-nucleotide leader, the authentic start codon plus the first
three codons of the S-message and authentic 3' sequences (Fig.
10A). These results led us to the conclusion that the block caused by
the endotoxin-induced mediators is posttranscriptional. The major block
appears to be prior to encapsidation, most probably at the level of
translation of viral RNAs, but an additional effect on a latter step
cannot be excluded.
Endotoxin is known to act mainly on monocytes and macrophages to
produce and release a broad range of proinflammatory mediators: cytokines, chemokines, lipid mediators such as leukotrienes or prostaglandins, and low-molecular-weight oxygen radicals, peroxide, and
nitric oxide (38, 47). In our studies, in which cultures of
hepatic NPC stimulated with endotoxin secreted antiviral mediators, polypeptides were identified to be responsible for the
antiviral effect. IFN-
(43) and IFN-
(42),
the only duck cytokines known so far, were identified to be among these
mediators. Unfortunately, cytokines such as TNF-
, involved in
regulation of HBV replication (16) and known to be induced
by endotoxin (33), have not yet been characterized in the
duck and thus could not be tested for. Furthermore, no blocking
antibody to any duck cytokine is available to determine to which extent
different cytokines contribute to the antiviral effect.
NPC preparations containing mainly Kupffer cells, the resident
macrophages of the liver, but not purified sinusoidal liver endothelial
cells did secrete antiviral mediators upon endotoxin stimulation. This
suggests that Kupffer cells mediate the inhibitory effect of endotoxin
on hepadnavirus replication. In most macrophages and in peripheral
blood mononuclear cells, CD14 functions as the receptor for bacterial
endotoxin. CD14 recognizes a complex of LPS and LPS-binding protein,
which is an excess serum protein. LPS binds to LPS-binding protein via
its lipid portion, lipid A (49). In our experiments, the
addition of serum containing LPS-binding protein was not necessary for
the endotoxin stimulation and lipid A could not substitute for LPS.
Recently, it was reported that the Kupffer cells, unlike other tissue
macrophages, do not bind endotoxin via CD14 (27). In
addition to the above mentioned experimental data, this supports our
conjecture that Kupffer cells are responsible for the cytokine-mediated
suppression of hepadnaviral replication.
In HBV transgenic mice, it has been highlighted that cytotoxic T
lymphocytes can inhibit HBV gene expression and replication noncytopathically by secreting antiviral cytokines (i.e., IFN-
, IFN-
, and TNF-
), which interrupt HBV replication (14,
15). In chimpanzees with acute HBV infection, noncytopathic
antiviral mechanisms are mainly responsible for clearance of HBV
infection (16). Cytokines were reported to activate two
different pathways in vivo in HBV transgenic mice: firstly, replicative
viral intermediates contained in nucleocapsids were removed from the
cytoplasm (15); secondly, viral RNAs were destabilized
posttranscriptionally (15, 17, 18). Recently, La autoantigen
was identified in transgenic mice as an RNA-binding protein that binds
to HBV transcripts and is associated with a cytokine-induced clearance
of viral RNA from the liver (18, 19). In our experiments
employing hepatocytes with an established DHBV infection and an
established pool of viral transcripts as in the transgenic mice the
number of transcripts remained constant. A similar phenomenon was
reported when the HBV transgenic mice were treated with interleukin-12
(6) that induced IFN-
/
, TNF-
, and IFN-
. Perhaps
posttranscriptional degradation of hepadnaviral transcripts requires
higher doses of cytokines than inhibition of translation of
hepadnaviral proteins.
In vitro infection experiments employing DHBV suggested that in the
presence of IFN-
viral capsids containing pregenomic RNA were
selectively depleted from the cytoplasm of newly infected hepatocytes.
In addition, IFN-
inhibited a core protein-dependent accumulation of
viral transcripts (44). Studies in the same system showed
that IFN-
inhibited DHBV replication after initial conversion
of the viral genomic DNA into cccDNA, but before the accumulation of progeny cccDNA; it seemed to inhibit the
accumulation of ssDNA-containing capsids during reverse transcription
or an earlier step in the viral replication cycle (42). In
our experiments employing various cytokines, an inhibitory effect was
observed independent of the encapsidation of pregenomic RNA. We cannot, however, exclude an additional effect on viral capsids.
The mechanism by which the endotoxin-induced cytokines block
hepadnaviral replication in the hepatocyte remains unknown. Cytokines could directly elicit their antiviral effect in the hepatocyte. Alternatively, they could stimulate NPC or even hepatocytes to secrete
antiviral effectors. In initial experiments, endotoxin-induced mediators did not elicit their inhibitory effect when inducible nitric oxide synthase was blocked in hepatocyte cultures,
suggesting that nitric oxide may be such an antiviral effector. This
hypothesis is in accordance with recent observations that Kupffer cells
induce nitric oxide production in hepatocytes upon endotoxin challenge (45) and that nitric oxide is one of the key regulators of
infection with different pathogens (26, 35). Taken together,
the results obtained in this study further strengthen our notion that
hepadnavirus gene expression and replication are very sensitive to
extracellular stimuli that influence the state of the host cell.
 |
ACKNOWLEDGMENTS |
We thank Heike Oberwinkler for excellent technical assistance,
Bärbel Glass for providing primary duck hepatocytes and DHBV16, Silke Hegenbarth for providing liver sinusoidal endothelial cells, and
Percy Knolle, Stephan Urban, Andreas Limmer, and Elizabeth Grgaczic for
discussion and helpful comments.
The work was in part supported by grants from the Deutsche
Forschungsgemeinschaft (PR 618-1) and from the BMBF (01KV9516/3). Uta
Klöcker received a fellowship from the Graduiertenkolleg "Gene
Expression of Pathogenic Microorganisms" of the Deutsche Forschungsgemeinschaft. Ulrike Protzer is supported by a
"Habilitationsprogramm der Ruprecht Karls-Universität
Heidelberg".
 |
FOOTNOTES |
*
Corresponding author. Mailing address: ZMBH, Im
Neuenheimer Feld 282, D-69120 Heidelberg, Germany. Phone:
49-69221-546830. Fax: 49-69221-545893. E-mail:
u.protzer{at}zmbh.uni-heidelberg.de.
 |
REFERENCES |
| 1.
|
Akarid, K.,
M. Sinet,
B. Desforges, and P. M. Gougerot.
1995.
Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo.
J. Virol.
69:7001-7005[Abstract].
|
| 2.
|
Alpini, G.,
J. O. Phillips,
B. Vroman, and N. F. LaRusso.
1994.
Recent advances in the isolation of liver cells.
Hepatology
20:494-514[CrossRef][Medline].
|
| 3.
|
Bartenschlager, R.,
M. Junker Niepmann, and H. Schaller.
1990.
The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation.
J. Virol.
64:5324-5232[Abstract/Free Full Text].
|
| 4.
|
Bazzigher, L.,
A. Schwarz, and P. Staeheli.
1993.
No enhanced influenza virus resistance of murine and avian cells expressing cloned duck Mx protein.
Virology
195:100-112[CrossRef][Medline].
|
| 5.
|
Blouin, A.,
R. P. Bolender, and E. R. Weibel.
1977.
Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study.
J. Cell Biol.
72:441-445[Abstract/Free Full Text].
|
| 6.
|
Cavanaugh, V. J.,
L. G. Guidotti, and F. V. Chisari.
1997.
Interleukin-12 inhibits hepatitis B virus replication in transgenic mice.
J. Virol.
71:3236-3243[Abstract].
|
| 7.
|
Farza, H.,
A. Salmon,
M. Hadchouel,
P. Tiollais, and C. Pourcel.
1987.
Hepatitis B surface antigen expression is regulated by sex steroids and glucocorticoids in transgenic mice.
Proc. Natl. Acad. Sci. USA
84:1187-1191[Abstract/Free Full Text].
|
| 8.
|
Folks, T. M.,
K. A. Clouse,
A. Justement,
A. Rabson,
E. Duh,
J. H. Kehrl, and A. S. Fauci.
1989.
Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T cell clone.
Proc. Natl. Acad. Sci. USA
86:2365-2368[Abstract/Free Full Text].
|
| 9.
|
Galle, P. R.,
H. J. Schlicht,
C. Kuhn, and H. Schaller.
1989.
Replication of duck hepatitis B virus in primary duck hepatocytes and its dependence on the state of differentiation of the host cell.
Hepatology
10:459-465[Medline].
|
| 10.
|
Ganem, D.
1996.
Hepadnaviridae: the viruses and their replication, p. 2703-2737.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 11.
|
Gathiram, P.,
M. T. Wells,
D. Raidoo,
U. J. Brock, and S. L. Gaffin.
1989.
Changes in lipopolysaccharide concentrations in hepatic portal and systemic arterial plasma during intestinal ischemia in monkeys.
Circ. Shock
27:103-109[Medline].
|
| 12.
|
Gilles, P. N.,
G. Fey, and F. V. Chisari.
1992.
Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice.
J. Virol.
66:3955-3960[Abstract/Free Full Text].
|
| 13.
|
Gripon, P.,
C. Diot,
A. Corlu, and C. Guguen Guillouzo.
1989.
Regulation by dimethylsulfoxide, insulin, and corticosteroids of hepatitis B virus replication in a transfected human hepatoma cell line.
J. Med. Virol.
28:193-199[Medline].
|
| 14.
|
Guidotti, L. G.,
P. Borrow,
M. V. Hobbs,
B. Matzke,
I. Gresser,
M. B. Oldstone, and F. V. Chisari.
1996.
Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver.
Proc. Natl. Acad. Sci. USA
93:4589-4594[Abstract/Free Full Text].
|
| 15.
|
Guidotti, L. G.,
T. Ishikawa,
M. V. Hobbs,
B. Matzke,
R. Schreiber, and F. V. Chisari.
1996.
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.
Immunity
4:25-36[CrossRef][Medline].
|
| 16.
|
Guidotti, L. G.,
R. Rochford,
J. Chung,
M. Shapiro,
R. Purcell, and F. V. Chisari.
1999.
Viral clearance without destruction of infected cells during acute HBV infection.
Science
284:825-829[Abstract/Free Full Text].
|
| 17.
|
Guilhot, S.,
L. G. Guidotti, and F. V. Chisari.
1993.
Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism.
J. Virol.
67:7444-7449[Abstract/Free Full Text].
|
| 18.
|
Heise, T.,
L. G. Guidotti,
V. J. Cavanaugh, and F. V. Chisari.
1999.
Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice.
J. Virol.
73:474-481[Abstract/Free Full Text].
|
| 19.
|
Heise, T.,
L. G. Guidotti, and F. Chisari.
1999.
La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA.
J. Virol.
73:5767-5776[Abstract/Free Full Text].
|
| 20.
|
Hild, M.,
O. Weber, and H. Schaller.
1998.
Glucagon treatment interferes with an early step of duck hepatitis B virus infection.
J. Virol.
72:2600-2606[Abstract/Free Full Text].
|
| 21.
|
Irving, M. G.,
F. J. Roll,
S. Huang, and D. M. Bissell.
1984.
Characterization and culture of sinusoidal endothelium from normal rat liver: lipoprotein uptake and collagen phenotype.
Gastroenterology
87:1233-1247[Medline].
|
| 22.
|
Johnston, D. E., and R. Jasuja.
1994.
Purification of cultured primary rat hepatocytes using selection with ricin A subunit.
Hepatology
20:436-444[CrossRef][Medline].
|
| 23.
|
Jungwirth, C.,
M. Rebbert,
K. Ozato,
H. J. Degen,
U. Schultz, and I. B. Dawid.
1995.
Chicken interferon consensus sequence-binding protein (ICSBP) and interferon regulatory factor (IRF) 1 genes reveal evolutionary conservation in the IRF gene family.
Proc. Natl. Acad. Sci. USA
92:3105-3109[Abstract/Free Full Text].
|
| 24.
|
Knolle, P. A.,
E. Loser,
U. Protzer,
R. Duchmann,
E. Schmitt,
K. Meyer zum Büschenfelde,
S. Rosejohn, and G. Gerken.
1997.
Regulation of endotoxin-induced IL-6 production in liver sinusoidal endothelial cells and Kupffer cells by IL-10.
Clin. Exp. Immunol.
107:555-561[CrossRef][Medline].
|
| 25.
|
Köck, J., and H. J. Schlicht.
1993.
Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity.
J. Virol.
67:4867-4874[Abstract/Free Full Text].
|
| 26.
|
Komatsu, T.,
N. Srivastava,
M. Revzin,
D. D. Ireland,
D. Chesler, and C. Shoshkes Reiss.
1999.
Mechanisms of cytokine-mediated inhibition of viral replication.
Virology
259:334-341[CrossRef][Medline].
|
| 27.
|
Lichtman, S. N.,
J. Wang, and J. J. Lemasters.
1998.
LPS receptor CD14 participates in release of TNF-alpha in RAW 264.7 and peritoneal cells but not in kupffer cells.
Am. J. Physiol.
275:G39-G46[Abstract/Free Full Text].
|
| 28.
|
Mathison, J., and R. Ulevitch.
1979.
The clearance, tissue distribution and cellular localization of intravenously injected lipopolysaccharide in rabbits.
J. Immunol.
123:2133-2143[Abstract/Free Full Text].
|
| 29.
|
McCuskey, R. S.,
P. A. McCuskey,
R. Urbaschek, and B. Urbaschek.
1984.
Species differences in Kupffer cells and endotoxin sensitivity.
Infect. Immun.
45:278-280[Abstract/Free Full Text].
|
| 30.
|
Mimura, Y.,
S. Sakisaka,
M. Harada,
M. Sata, and K. Tanikawa.
1995.
Role of hepatocytes in direct clearance of lipopolysaccharide in rats.
Gastroenterology
109:1969-1976[CrossRef][Medline].
|
| 31.
|
Nassal, M., and H. Schaller.
1996.
Hepatitis B virus replication an update.
J. Viral Hepat.
3:217-226[Medline].
|
| 32.
|
Pertile, T. L.,
K. Karaca,
J. M. Sharma, and M. M. Walser.
1996.
An antiviral effect of nitric oxide: inhibition of reovirus replication.
Avian Dis.
40:342-348[CrossRef][Medline].
|
| 33.
|
Peters, T.,
U. Karck, and K. Decker.
1991.
LPS activation of rat Kupffer cells participation of tumor necrosis factor, prostaglandin E2, glucocorticoids and protein synthesis, p. 6-9.
In
E. Wisse, D. L. Knook, and R. S. McCuskey (ed.), Cells of the hepatic sinusoid, vol. 3. The Kupffer Cell Foundation, Leiden, The Netherlands.
|
| 34.
|
Protzer, U.,
M. Nassal,
P. W. Chiang,
M. Kirschfink, and H. Schaller.
1999.
Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection.
Proc. Natl. Acad. Sci. USA
96:10818-10823[Abstract/Free Full Text].
|
| 35.
|
Rimmelzwaan, G. F.,
M. M. Baars,
P. de Lijster,
R. A. Fouchier, and A. D. Osterhaus.
1999.
Inhibition of influenza virus replication by nitric oxide.
J. Virol.
73:8880-8883[Abstract/Free Full Text].
|
| 36.
|
Rolph, M. S.,
I. A. Ramshaw,
K. A. Rockett,
J. Ruby, and W. B. Cowden.
1996.
Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance.
Virology
217:470-477[CrossRef][Medline].
|
| 37.
|
Rothmann, K.,
M. Schnoelzer,
G. Radziwill,
E. Hildt,
K. Moelling, and H. Schaller.
1998.
Host cell-virus crosstalk: phosphorylation of a hepatitis B virus envelope protein mediates intracellular signalling.
J. Virol.
72:10138-10147[Abstract/Free Full Text].
|
| 38.
|
Schletter, J.,
H. Heine,
A. J. Ulmer, and E. T. Rietschel.
1995.
Molecular mechanisms of endotoxin activity.
Arch. Microbiol.
164:383-389[CrossRef][Medline].
|
| 39.
|
Schlicht, H. J.,
C. Kuhn,
B. Guhr,
R. J. Mattagliano, and H. Schaller.
1987.
Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins.
J. Virol.
61:2280-2285[Abstract/Free Full Text].
|
| 40.
|
Schlicht, H. J.,
J. Salfeld, and H. Schaller.
1987.
The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation.
J. Virol.
61:3701-3709[Abstract/Free Full Text].
|
| 41.
|
Schödel, F.,
T. Weimer,
D. Fernholz,
R. Schneider,
R. Sprengel,
G. Wildner, and H. Will.
1991.
The biology of avian hepatitis B viruses, p. 53-80.
In
A. McLachlan (ed.), Molecular biology of the hepatitis B virus. CRC Press, Boca Raton, Fla.
|
| 42.
|
Schultz, U., and F. V. Chisari.
1999.
Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes.
J. Virol.
73:3162-3168[Abstract/Free Full Text].
|
| 43.
|
Schultz, U.,
J. Köck,
H. J. Schlicht, and P. Staeheli.
1995.
Recombinant duck interferon: a new reagent for studying the mode of interferon action against hepatitis B virus.
Virology
212:641-649[CrossRef][Medline].
|
| 44.
|
Schultz, U.,
J. Summers,
P. Staeheli, and F. V. Chisari.
1999.
Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes.
J. Virol.
73:5459-5465[Abstract/Free Full Text].
|
| 45.
|
Shiratori, Y.,
K. Ohmura,
Y. Hikiba,
M. Matsumura,
T. Nagura,
K. Okano,
K. Kamii, and M. Omata.
1998.
Hepatocyte nitric oxide production is induced by Kupffer cells.
Dig. Dis. Sci.
43:1737-1745[CrossRef][Medline].
|
| 46.
|
Summers, J.,
P. M. Smith, and A. L. Horwich.
1990.
Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification.
J. Virol.
64:2819-2824[Abstract/Free Full Text].
|
| 47.
|
Sweet, M. J., and D. A. Hume.
1996.
Endotoxin signal transduction in macrophages.
J. Leukoc. Biol.
60:8-26[Abstract].
|
| 48.
|
Tuttleman, J. S.,
C. Pourcel, and J. Summers.
1986.
Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells.
Cell
47:451-460[CrossRef][Medline].
|
| 49.
|
Ulevitch, R., and P. Tobias.
1995.
Receptor-dependent mechanism of cell stimulation by bacterial endotoxin.
Annu. Rev. Immunol.
13:437-457[CrossRef][Medline].
|
| 50.
|
Verani, A.,
G. Scarlatti,
M. Comar,
E. Tresoldi,
S. Polo,
M. Giacca,
P. Lusso,
G. Siccardi, and D. Vercelli.
1997.
C-C chemokines released by lipopolysaccharide-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells.
J. Exp. Med.
185:805-816[Abstract/Free Full Text].
|
Journal of Virology, June 2000, p. 5525-5533, Vol. 74, No. 12
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Narayan, R., Buronfosse, T., Schultz, U., Chevallier-Gueyron, P., Guerret, S., Chevallier, M., Saade, F., Ndeboko, B., Trepo, C., Zoulim, F., Cova, L.
(2006). Rise in gamma interferon expression during resolution of duck hepatitis B virus infection.. J. Gen. Virol.
87: 3225-3232
[Abstract]
[Full Text]
-
Ehlers, I., Horke, S., Reumann, K., Rang, A., Grosse, F., Will, H., Heise, T.
(2004). Functional Characterization of the Interaction between Human La and Hepatitis B Virus RNA. J. Biol. Chem.
279: 43437-43447
[Abstract]
[Full Text]
-
Walters, K.-A., Joyce, M. A., Addison, W. R., Fischer, K. P., Tyrrell, D. L. J.
(2004). Superinfection Exclusion in Duck Hepatitis B Virus Infection Is Mediated by the Large Surface Antigen. J. Virol.
78: 7925-7937
[Abstract]
[Full Text]
-
Nochi, H., Aoki, N., Oikawa, K., Yanai, M., Takiyama, Y., Atsuta, Y., Kobayashi, H., Sato, K., Tateno, M., Matsuno, T., Katagiri, M., Xing, Z., Kimura, S.
(2003). Modulation of Hepatic Granulomatous Responses by Transgene Expression of DAP12 or TREM-1-Ig Molecules. Am. J. Pathol.
162: 1191-1201
[Abstract]
[Full Text]
-
Klocker, U., Oberwinkler, H., Kurschner, T., Protzer, U.
(2003). Presence of Replicating Virus in Recombinant Hepadnavirus Stocks Results from Recombination and Can Be Eliminated by the Use of a Packaging Cell Line. J. Virol.
77: 2873-2881
[Abstract]
[Full Text]
-
Breiner, K. M., Urban, S., Glass, B., Schaller, H.
(2001). Envelope Protein-Mediated Down-Regulation of Hepatitis B Virus Receptor in Infected Hepatocytes. J. Virol.
75: 143-150
[Abstract]
[Full Text]